Stanley H. Appel Department of Neurology

Medicine & Life Sciences

1. (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine 24%
2. Age of Onset 16%
3. Alleles 16%
4. Alzheimer Disease 63%
5. Amyloid 20%
6. Amyotrophic Lateral Sclerosis 95%
7. Amyotrophic lateral sclerosis 1 13%
8. Animal Models 9%
9. Antibodies 12%
10. Ataxia 23%
11. Atrophy 13%
12. Biomarkers 23%
13. Blood Vessels 13%
14. Brain 67%
15. Brain Diseases 11%
16. Calcium 10%
17. Cerebellar Ataxia 11%
18. Cerebellum 9%
19. Cerebrospinal Fluid 19%
20. Cholinergic Agents 10%
21. Cholinergic Receptors 20%
22. Clinical Trials 13%
23. Cognition 17%
24. Cognitive Dysfunction 33%
25. Deep Brain Stimulation 25%
26. Dementia 33%
27. Disease Progression 20%
28. Dopamine 10%
29. Dopamine Agonists 10%
30. Dopamine Plasma Membrane Transport Proteins 11%
31. Dyskinesias 11%
32. Dystonia 14%
33. Epilepsy 10%
34. Essential Tremor 35%
35. Finches 9%
36. Fluorodeoxyglucose F18 10%
37. Friedreich Ataxia 13%
38. Frontotemporal Dementia 9%
39. GABA-A Receptors 10%
40. Gait 14%
41. Genes 24%
42. Headache 29%
43. Huntington Disease 20%
44. Immunoglobulin G 11%
45. Immunoglobulins 9%
46. In Vitro Techniques 12%
47. Inflammation 9%
48. Injections 11%
49. Levodopa 16%
50. Ligands 10%
51. Machado-Joseph Disease 14%
52. Magnetic Resonance Imaging 18%
53. Membranes 13%
54. Memory 10%
55. Mental Status and Dementia Tests 11%
56. Microglia 19%
57. Microsatellite Repeats 10%
58. Migraine Disorders 19%
59. Motor Neurons 45%
60. Movement Disorders 14%
61. Multiple Sclerosis 10%
62. Muscles 19%
63. Muscular Dystrophies 13%
64. Mutation 25%
65. Myasthenia Gravis 14%
66. Myotonic Dystrophy 44%
67. Nervous System 12%
68. Nervous System Diseases 13%
69. Neurodegenerative Diseases 19%
70. Neuroimaging 34%
71. Neurologists 12%
72. Neurology 20%
73. Neurons 14%
74. Pallidotomy 18%
75. Parkinson Disease 100%
76. Parkinsonian Disorders 16%
77. Pathology 19%
78. Phenotype 17%
79. Placebos 24%
80. Population 13%
81. Positron-Emission Tomography 34%
82. Proteins 17%
83. Regulatory T-Lymphocytes 10%
84. Restless Legs Syndrome 58%
85. Rolipram 12%
86. Safety 14%
87. Seizures 17%
88. Single-Photon Emission-Computed Tomography 25%
89. Skeletal Muscle 14%
90. Spinal Cord 20%
91. Spinocerebellar Ataxia 10 47%
92. Spinocerebellar Ataxias 31%
93. Stroke 44%
94. Stuttering 11%
95. Therapeutics 28%
96. Tremor 36%
97. Tropical Spastic Paraparesis 12%
98. Vascular Dementia 28%
99. White Matter 19%
100. Wounds and Injuries 13%